- Biopsy devices are essential tools used to extract tissue samples from patients for diagnostic purposes, primarily in cancer detection. They are crucial for procedures such as needle biopsies, surgical biopsies, and endoscopic biopsies
- The demand for biopsy devices is significantly driven by the rising prevalence of cancer, increasing adoption of minimally invasive diagnostic techniques, and advancements in biopsy technology
- North America is expected to dominate the biopsy devices market with largest market share of 43.2%, due to advanced healthcare infrastructure, higher adoption of early cancer detection technologies, and the presence of key market players
- Asia-Pacific is expected to be the fastest growing region in the biopsy devices market during the forecast period due to the rising cancer incidence, improving healthcare systems, and increasing demand for advanced diagnostic tools
- Needle-based biopsy instruments segment is expected to dominate the market with a largest market share of 43.2% due to increasing demand for needle-based biopsy guns to collect samples from soft tissues of internal organs. In addition, the rising need for rapid and gentle procurement of cell samples for biopsy has led to the development of technologically advanced biopsy devices such as vacuum-assisted biopsy (VAB) devices
